AI-designed proteins improved targeted DNA insertion in cultured cells, with one variant doubling the performance of an ...
A team of biochemists at the University of Minnesota (UMN) accidentally discovered that a single bacterial DNA repair gene ...
Jonathan was already a fully grown tortoise when he arrived on the remote island of St. Helena in 1882. He has since outlived ...
Senescent cells in mouse lung and skin share a fat-linked signal a laser can detect, a step toward finding them without a ...
A new study shows that the RNA cap-modifying enzyme PCIF1 drives tumor growth and radioresistance, and that removing its m6Am mark on MSH2 activates the cGAS-STING immune pathway to boost radiotherapy ...
Researchers at the University of Malta and the University of Pittsburgh trained a modified U-Net on 95,000 synthetic ...
A major clinical trial involving 410 people with early Parkinson's disease has found no clinical benefit from nicotinamide ...
A genetic analysis of Jonathan, believed to be about 194, identified gene variants linked to DNA repair and reduced inflammation. Researchers say studying the tortoise may help guide future work on ...
The Acura RDX beats the BMW X3 with 272 hp, a 6-year powertrain warranty, and a starting MSRP $6,200 lower—plus more standard ...
They thought it might explain why their health had diverged. Instead, it stirred up feelings that weren’t so easily ...
The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...
Morning Overview on MSN
Atezolizumab plus chemo won FDA approval for some stage III colon cancers
On Oct. 8, 2026, the Food and Drug Administration approved atezolizumab, sold as Tecentriq by Genentech, together with chemotherapy for adults and children as young as two with Stage III colon cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results